entacapone orion
orion corporation - entacapone - parkinson disease - anti-parkinson drugs - entacapone is indicated as an adjunct to standard preparations of levodopa / benserazide or levodopa / carbidopa for use in adult patients with parkinson's disease and end-of-dose motor fluctuations, who cannot be stabilised on those combinations.
morinda plus tablet
major interest sdn bhd - morinda citrifolia/noni; honey, dried powder; channa striatus bloch/haruan ikan -
noni fruit product
morinda (malaysia) sdn. bhd. - morinda citrifolia (noni) fruit juice -
beclomet easyhaler 200 mcginhalation dose
orion pharma (sg) pte. ltd. - beclomethasone dipropionate (micronized) - powder, metered - 200mcg/metered dose - beclomethasone dipropionate (micronized) 200mcg/metered dose
orion temozolomide
orion laboratories (nz) ltd - temozolomide 180mg - capsule - 180 mg - active: temozolomide 180mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma
buventol easyhaler 100 mcginhalation dose
orion pharma (sg) pte. ltd. - salbutamol sulphate eqv salbutamol - powder, metered - 100 mcg/dose - salbutamol sulphate eqv salbutamol 100 mcg/dose
buventol easyhaler 200 mcginhalation dose
orion pharma (sg) pte. ltd. - salbutamol sulphate eqv salbutamol - powder, metered - 200 mcg/dose - salbutamol sulphate eqv salbutamol 200 mcg/dose
giona easyhaler 200 mcgdose inhalation powder
orion pharma (my) sdn. bhd. - budesonide -
giona easyhaler 100 mcgdose inhalation powder
orion pharma (my) sdn. bhd. - budesonide -
orion temozolomide
orion laboratories (nz) ltd - temozolomide 100mg - capsule - 100 mg - active: temozolomide 100mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma